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ABSTRACT
BACKGROUND AND AIM
Unrelated HSC donor registries in India require donor-pool expansion.
Voluntary blood donors are suitable for motivation regarding unrelated HSC
donation. The aim of the study was to assess the knowledge, attitude and
behaviour (KAB) regarding hematopoietic stem cell (HSC) donation and
unrelated HSC donor registry among voluntary blood donors in Chennai.
MATERIALS AND METHODS
422 voluntary blood donors over a period of one year (July 2015 - June
2016) were interviewed individually as per study questionnaire. Level of
knowledge was categorized as “desirable” and “below desirable” based on
response to 6 questions. Attitude was assessed based on willingness for HSC
donation, prior to and after providing information on HSC donation and
unrelated HSC donor registry. Behaviour was assessed by registration status
at an unrelated HSC donor registry. Data analysis was done using SPSS
software. Categorical data was expressed in frequency and percentage. Chi-
square test was used to find association between donor-related factors and
willingness for unrelated HSC donation.
RESULTS
Among 422 voluntary blood donors, 417 donors had “below desirable”
level of knowledge.  Majority (224 donors) were not sure of their decision
about HSC donation, initially. After providing information, 151 donors
expressed willingness for unrelated HSC donation. Major reason among those
who did not have a positive attitude about HSC donation was concern about
adverse events after HSC donation. 139 donors responded that others’ opinion
would influence their attitude towards HSC donation, of which, 79.9% of
them considered the opinion of family members as important. 3 donors had
already registered at an unrelated HSC donor registry.
Level of knowledge was significantly associated (p = 0.028) with
willingness for unrelated HSC donation. Factors which were not significantly
associated with willingness for unrelated HSC donation were age, gender,
marital status, education, number of units of blood donated, prior
plateletpheresis donation and having a known person who needed HSCs as
treatment.
CONCLUSION
Awareness programmes and recruitment drives have to be intensified
among voluntary blood donors in order to enrol them as volunteers for
unrelated HSC donation. Involving persons who have already donated HSCs
and key persons like family members of potential volunteers, may be useful
strategies for motivation regarding unrelated HSC donation.
Keywords
Knowledge, attitude, willingness, behaviour, hematopoietic stem cells
(HSCs), donation, registry, unrelated, voluntary blood donor
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INTRODUCTION
1INTRODUCTION
Worldwide, about 75 unrelated hematopoietic stem cell (HSC) donor
registries are in existence in about 53 countries, including India.1 The
databases of these registries contain a list of Human leukocyte antigen
(HLA)-typed individuals who have committed voluntarily to donate HSCs
when identified as a potential HLA-match for a patient anywhere in the world
seeking unrelated HSC donors for transplantation. Currently, the global
database has about 28 million people registered as potential unrelated HSC
donors.1
In allogeneic HSC transplantation (HSCT), the success rate depends
upon the degree of allele-level HLA match between the donor and the
recipient.2 The donor and the recipient have a higher chance of being HLA-
compatible when they arise from the same ethnicity.3 Hence, the amount of
representation of a particular ethnic or racial group in these registries is of
importance in finding a matched unrelated donor for a patient.4 Additional
challenges faced by registries are donor retirement (unrelated HSC donation is
age-restricted), donor’s medical suitability at the time of HSC donation,
personal withdrawal requests from donor5 and donor attrition (~10% after a
year).6
2In India, the number of patients potentially curable by allogeneic
HSCT is high. The incidence rate of acute myeloid leukaemia and acute
lymphoblastic leukaemia is 3.6 and 1.6 per 100,000 persons per year.7 About
10,000 children are born with thalassemia major each year and the incidence
of aplastic anaemia is estimated to be 6000 cases per year.8 The first
allogeneic HSC transplant in India was performed in 1983.9 Since then, there
has been a steady progress with close to a dozen centres in the country
currently performing HSC transplants.9 The number of allogeneic HSC
transplants have increased to about 2445 in 2010. Half of these transplants
were performed for various types of leukaemia, 26% were for thalassemia and
other haemoglobinopathies and 18% of the allogeneic HSC transplants were
for aplastic anaemia.7 The majority of these transplants were performed using
patients’ siblings as donors of HSCs.4 However, it has been found that only
39.3% of the patients in India have an HLA-matched sibling donor.9
In India, the first unrelated HSC donor registry was launched in 1994
in New Delhi.10 Subsequently, such registries were also set up in few other
states of the country and currently, a total of about 1.5 lakh volunteers have
registered as potential unrelated HSC donors. The number of unrelated HSC
donations in India have gradually increased to 150 in the last five years since
the first such donation in 2011.11,12 However, the number of requests for
unrelated HSC donors have increased from 465 in 2012 to 797 in 2014. There
are at least 30 to 50 requests for unrelated HSC donors every month13 and
3close to 1000 patients are waiting to find a matched unrelated donors in
India.12 Given the current registry size in India, the probability of an Indian
patient finding a HLA-compatible unrelated HSC donor is higher in the multi-
national registry than in the registries in the country. However, dependence on
a foreign registry is very costly.14
Although umbilical cord blood (UCB) is an alternative source of HSCs
for transplantation, it has certain disadvantages like delayed platelet and
neutrophil engraftment due to inadequate HSC content, especially, for larger
patients, one-time usage from a single donor, limited ability to perform post-
transplant donor-derived cellular therapy and expensive infrastructure
required for banking.15 There are only three public cord blood banks in India,
storing 5000 units collectively.16 It has been estimated that even with a UCB
registry size of 25,000 units, only 18.3 % of Indian patients would have a 6/6
match.5 Hence, recruiting more volunteers into the unrelated HSC donor
registries in India represents a likely option to bridge the gap between demand
and supply of HSCs for transplantation.
The recruitment of potential unrelated HSC donors often takes place in
a blood bank.17 It is presumed that voluntary blood donors have high internal
motivation to donate in contrast to the general public who are likely to be
subjected to peer pressure to become a part of the registry.18 Taking part in
the blood donation process is said to lead to several real and potential benefits
that do not accrue from recruitment approaches to a more general public. It is
4presumed that individuals who demonstrate enough altruism to donate blood
on a voluntarily non-remunerated basis might be more likely to follow
through as HSC donors when called upon.19 Also, similarity exists between
blood and HSC donation in terms of donor eligibility criteria.20 Recruitment
of HSC donors at a Blood Bank also obviates the need for a separate sample
collection area from prospective donors or a donor-tracking system for
follow-up of the registered donors. Strategy aimed at recruiting voluntary
blood donors can yield large numbers of potential unrelated HSC donors.19
Many experts in the field of HSCT in India have stated that there is a
need for more awareness regarding unrelated HSC donation in the
country.21,14 India is ranked at the eleventh position in the list of the most
productive countries in bone marrow research. However, there are limited
scientific publications focussing on unrelated HSC donor recruitment
activities in the country.22,7 As per the knowledge, attitude and behaviour
(KAB) model, knowledge is a prerequisite to the intentional performance of a
health-related behaviour. Information leads to accumulation of knowledge
which changes attitude, behaviour, or both.23 Since voluntary blood donors
represent a suitable target for motivation regarding unrelated HSC donation, a
study regarding the existing KAB among them would be helpful in
formulating strategies to recruit them as potential unrelated HSC donors.
AIM & OBJECTIVES
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AIM
To study the knowledge, attitude and behaviour (KAB) regarding
hematopoietic stem cell (HSC) donation and unrelated HSC donor registry
among voluntary blood donors at the Department of Transfusion Medicine,
The Tamil Nadu Dr. M.G.R Medical University, Guindy , Chennai.
OBJECTIVES
? To estimate the awareness and willingness of voluntary blood donors
regarding hematopoietic stem cell (HSC) donation and unrelated HSC
donor registry.
? To compare the willingness of voluntary blood donors before and after
providing information about HSC donation and unrelated HSC donor
registry.
REVIEW OF LITERATURE
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Blood Transfusion Service (BTS) forms an important part of health
care in various medical and surgical specialties. Patients may require blood
both in routine and emergency situations. The annual requirement for blood in
India is about 10 million units.24 The backbone of BTS is a blood donor, since
the only source of blood to the blood bank is a blood donor.25 Blood from
voluntary, non-remunerated donors is considered to be the safest since they
carry lower risk for transfusion-transmitted infections.26 In 1975, the World
Health Organization recognized its value and called on its member states to
promote voluntary non-remunerated donations.27 In India, voluntary blood
donation has progressively increased from 54.5% of the donations in 2006 to
79% in 2015-16.28 Voluntary blood donation contributes to more than 80% of
the blood collected in Tamil Nadu.24
VOLUNTARY NON-REMUNERATED BLOOD DONOR29
? A person who gives blood, plasma or other blood components of
his/her own free will and receives no payment for it, either in the form
of cash or in-kind which could be considered a substitute for money.
This includes time off work, other than reasonably needed for the
donation and travel. Small tokens, refreshments and reimbursement of
7the direct travel costs are compatible with voluntary, non-remunerated
blood donation.
? "Voluntary" blood donation refers to "unpaid, non-remunerated" blood
donation.
? An altruistic donor who gives blood freely and willingly without
receiving money or any other form of payment.
Categories of voluntary blood donor 29
a. New voluntary donor - A voluntary non-remunerated blood donor
who has never donated blood before.
b. Lapsed voluntary donor - A voluntary non-remunerated blood donor
who has given blood in the past but does not fulfill the criteria for a
regular donor.
c. Regular voluntary donor - A voluntary non-remunerated blood donor
who donates blood on a regular basis without any break for a longer
duration between two donations. i.e., at least three times, the last
donation being within the previous year, and continues to donate
regularly at least once per year.
8THEORIES OF BLOOD DONATION
Many sociological and psychological theories exist which explain why
and how an individual decides to donate blood. Some theories also attempt to
explain repeat donation of blood.
The various theories of blood donation are 26
a. Opponent-process theory: Donors experience a “warm-glow” after
donation, which may be an opponent process in response to negative
feelings experienced before and during initial donations. This theory
explains why some donors repeat the process of blood donation.
b. Attribution theory: It suggests that people who have taken an action
(eg, donating blood) without external coercion or large reward, are
likely to attribute to themselves a predisposition toward that action and
so, they are more likely to repeat that action, in future.
c. Model of commitment : It encompasses processes like coping with
and neutralizing the negative aspects of donation, developing
internalized motives for donation, developing a behavioural intention
to continue giving blood and forming a self-sustaining habit of
donation.
d. The theory of reasoned action: All behavior is preceded by a
behavioural intention that can be measured by seeking an estimate of
9the probability of acting on that speci?c behavior. Intention is
influenced by the individual’s attitude toward performing the act and
the perceived expectations of others.
e. Theory of planned behaviour: The theory of planned behaviour has
been the main psychological framework applied to study blood
donation behaviour. It states that behaviour is determined by intentions
to act and intentions are predicted by subjective norms, attitudes, and
perceived behavioural control.
RECRUITMENT OF VOLUNTARY BLOOD DONORS
One of the most important functions of a blood bank is to recruit
adequate numbers of voluntary blood donors to ensure adequate supply of
blood to provide for patient needs. Recruitment campaigns generally focus on
altruism, as voluntary blood donation is considered an archetypal altruistic act
and altruism is the most common self-reported motive for blood donation.30
The theory-driven motives for altruistic behaviour which are
differentially related to blood donation are 30
a. Pure altruism: It describes an individual’s ultimate desire to help
others at a personal cost, without reward.
b. Warm glow: It describes the personal bene?t arising through positive
emotional gains from the act of donation.
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c. Reluctant altruism: It describes when co-operation occurs due to a
lack of trust that others will donate.
d. Social responsibility: It re?ects a sense of duty to donate blood.
e. Hedonism: It is an egoistic motive, whereby helping is used to
increase personal gains without concern for the recipient’s welfare.
f. Reputation building: It operates via indirect reciprocity, with people
more likely to help those who have a good reputation for helping.
g. Kin selection: Individuals show preferential helping towards family
members.
VOLUNTARY BLOOD DONOR AS UNRELATED HEMATOPOIETIC
STEM CELL DONOR
Unrelated hematopoietic stem cell (HSC) donation is an act of
altruism.31 Volunteerism is one of the basic principles of becoming an
unrelated HSC donor. At the time of recruitment, emphasis is made on the
voluntary nature of the donation.32 The recruitment of a potential HSC donor
occurs in a number of places including a blood bank.17 Initially, most persons
joining unrelated HSC donor registries were recruited from plateletpheresis
panels but the potential of enrolling voluntary whole blood donors was
explored and it was found that those who were willing to join the registries
had history of frequent whole blood donations.19 HSC donation requires a
11
much higher level of commitment that that associated with blood donation.33
Regarding medical suitability for HSC donation, HSC transplantation has the
potential to transmit blood-borne illnesses which are inclusive of those
conditions screened prior to blood transfusion.31 Potential donors of HSCs are
evaluated using selection and exclusion criteria which include those
applicable to donors of blood and blood components.20 In June 2008, a pilot
project was conducted in Bengaluru, India to enrol voluntary unrelated HSC
donors from voluntary whole blood donors. 24.79% of the voluntary whole
blood donors had registered as potential HSC donors after receiving
appropriate information.34 Thus, voluntary whole blood donors are potential
target groups for recruitment as unrelated HSC donors.
HSC DONATION
HSCs are donated for transplantation with the intention of repopulating
and replacing the hematopoietic system in total or in part.35 The principles of
HSC donation and transplantation are based on the biology of HSCs.
Hematopoietic stem cells (HSCs)
HSCs are one of the longest studied somatic stem cells.36 They
originate during the third wave of hematopoiesis in the embryo and eventually
seed the bone marrow which is the primary site of its maintenance,
postnatally.37,38 Hematopoiesis becomes restricted to the flat bones and the
proximal ends of humerus and femur by about 20 years of age.39 The
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properties of HSCs are multipotency, quiescence and self-renewal allowing
for long life span, ability to maintain an undifferentiated state in the HSC
niche and long-term repopulation, with the ability to engraft in vivo and
reconstitute hematopoietic tissue upon transplantation.40 Human HSCs are
enriched in the Lin? CD34+ CD38? CD90+ population of hematopoietic
cells41
ALLOGENEIC HSC TRANSPLANTATION (HSCT)
HSCT is termed “allogeneic” when the patient receives HSC graft
from a healthy donor.42
Historical aspects
The earliest attempt to use marrow for therapy was in 1939 when few
millilitres of marrow were infused intravenously to a patient diagnosed with
aplastic anaemia but was not met with any success. Following World War II,
murine experimental studies revealed that the bone marrow contained cellular
component which, upon transplantation, was capable of rescuing lethally
irradiated mice. This led to clinical experiments in human beings diagnosed
with haematological malignancies. The first allogeneic HSCT was performed
by E. Donnall Thomas in 1957, at a time when little was known about Human
leukocyte antigen (HLA). The survival rate was not satisfactory. However, he
continued his clinical trials in patients laying the foundation for the principles
currently followed in HSCT. Allogeneic HSCT has evolved in many ways
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since the 1950s; in terms of indications, conditioning regimens, graft and
donor sources.42,43 In India, the first successful allogeneic bone marrow
transplantation was done in 1983.9
Indications for allogeneic HSCT
Leukaemia and myeloid malignancies [acute myeloid leukaemia
(AML), acute lymphoblastic leukaemia (ALL), myelodysplastic syndromes
and myeloproliferative disorders] are the most common indications for
allogeneic transplants. The most common non-malignant indications include
aplastic anaemia and other bone marrow failure states, hemoglobinopathies
like thalassemia, severe combined immunede?ciency and metabolic disorders
involving hematopoietic cells.44 In patients with severe aplastic anaemia,
AML, ALL, or CML who survived 2 years post-transplant, survival at 5 years
post-transplant was 89%. The risk of death of survivors who underwent
transplantation for severe aplastic anaemia had returned to that of the normal
population, matched for age, sex, ethnicity, and nationality, by the sixth year
post-transplant.45
 HSC collection from bone marrow and peripheral blood
HSCs can be collected from the bone marrow and peripheral blood.
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Bone marrow donation
Bone marrow is the obvious source of HSCs and was the mainstay for
transplantation for many years.46 Marrow still accounts for about 25% of the
transplants for allogeneic recipients.47
It is an invasive surgical procedure done under general or regional
anesthesia.48 Brief hospitalization was necessary previously but it is now
possible to collect marrow as an outpatient procedure. The volume of marrow
donated is based on the target cell dose (between 2 and 5 X 108 nucleated
cells/kg and between 2 and 5 X 106 CD34+ cells/kg of recipient weight) for
the transplant.49 A maximum of 20 ml/ kg of donor weight is permitted. About
1 to 3 autologous blood units are collected from almost all donors prior to the
procedure.48 The syringes are heparinized with 1 mL of a 100 U/mL heparin
solution. 1000 to 1500 mL of marrow is typically collected, 3 to 10 mL at a
time, from multiple punctures of the posterior iliac crests. The marrow is
drained into a collection apparatus that contains a ?lter to remove bone chips,
clots, fat, and ?brin. It also contains heparin at a concentration of at least 10
U/mL in the final product.49
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Adverse events of marrow donation
The most common symptoms are pain (at the collection site and lower
back) and fatigue. Pain may also occur at the bandage and intravenous site or
while sitting and is mostly of mild grade. Nausea, vomiting and sore throat are
common with general anaesthesia. Other symptoms are headache and fever.
87% of the donors recover completely within 1 month after donation.
Minor complications occur in 6% to 20% of marrow donations and
include transient hypotension, syncope, severe post-spinal headache, excess
pain, unexpected hospitalization, and minor infections.
Serious complications occur in 0.1%-0.3% of the donations and the
risks are of various categories. Anaesthetic risks due to reactions to
anaesthetic agents (hypersensitivity reactions, malignant hyperthermia,
arrhythmias), hypotension and problems with intubation or intravenous
catheter insertion. Risk of major infections at the site of marrow collection,
line insertions or at distant sites, e.g., pneumonia. Antibiotic therapy also
carries risk of adverse reactions. Risk of mechanical injuries like bone
damage, nerve damage or entry of a collection needle into a blood vessel, an
organ or the spinal canal. Hemorrhage can cause pain from compression of
soft tissues. Decrease in haemoglobin leading to 76% of the donors receiving
at least 1 autologous red blood cell unit during or shortly after marrow
harvest. The likelihood of needing allogeneic blood transfusion is
16
0.25%.Other haematological changes like mild increase in WBC values and
decrease in platelet counts immediately post-donation return to baseline
values, one month post-donation.
Pregnancy is considered an absolute contraindication to marrow
donation for unrelated recipients.
The risk of death with marrow donation is estimated to be ~1 in
10,000.Two of the six reported deaths in marrow donors were due to cardiac
arrest and occurred before the donation procedure could be done. The
remaining 4 were from ventricular fibrillation, respiratory arrest, myocardial
infarction and pulmonary embolism. 48,50
Peripheral blood stem cell (PBSC) donation
The peripheral blood of healthy individuals has less than 0.1% HSCs.49
However, various pharmacological agents can mobilize HSCs from the
marrow and increase their numbers in the peripheral blood which can then be
collected by apheresis. Over the past two decades, this has become the
preferred route of HSC collection, accounting for about 70% of unrelated
adult donations.31
Recombinant human Granulocyte-colony-stimulating factor (rhG-CSF)
is the most commonly used agent.51 It is available in various forms but the
non-glycosylated form is the agent of choice in normal donors. During G-
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CSF-induced mobilization, granulocyte proteases are released in large
amounts in active form in the marrow stroma which inactivate the factors
retaining HSCS within the marrow like Stroma-derived factor (SDF)-1 and its
receptor, vascular cell adhesion molecule-1 (VCAM-1) and c-Kit receptor.52
A small proportion of healthy allogeneic donors do not mobilize adequately,
especially, when there is a major weight discrepancy between donor and
recipient. Novel mobilizing agents are being investigated to overcome this
problem.53
PBSC donors receive subcutaneous injections of G-CSF once in a day
at a dose of 5 to 20 µg/kg .Total white cell count and CD34 percentage are
measured to determine the optimal time to donate, which is usually on the
fifth day after initiation of G-CSF.48 PBSC donation is mostly an outpatient
procedure.54 Through peripheral venous access, leukapheresis is performed
which removes the buffy coat containing HSCs and returns the red cells,
plasma and platelets back to the donor.31 Central venous access is needed in
case of poor vascular access or multiple apheresis procedures.54 The volume
of whole blood processed is about 12 to 24 litres per donation. If the required
number of cells are not collected, the donor may be asked to donate again the
next day.48
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Adverse events of PBSC donation
Symptoms are mostly related to the use of G-CSF. Majority (97%) of
the donors develop mild to moderate bone pain which is mostly48 diffuse but
may be prominent in the spine, hips or pelvis, and ribs and resolves promptly
when G-CSF is discontinued or with non-narcotic analgesics.50 Other
symptoms are myalgia, headache, insomnia, flu-like symptoms, sweating,
anorexia, fever, chills, and nausea and are mostly mild in nature.54
Minor apheresis-related adverse events occur in about 20% of the
donors.54 Bruise, hematoma and minor bleeding are related to securing venous
access at antecubital veins. Symptoms of hypocalcemia (perioral numbness,
paraesthesia and carpopedal spasm) requiring oral or parental calcium
supplementation are due to anticoagulant Acid Citrate Dextrose used in
apheresis.50
G-CSF administration causes dramatic increase in the peripheral blood
leucocyte counts, especially, neutrophils and modest decrease in platelet
counts. Post-donation, mild neutropenia, lymphopenia and anaemia are
common for a few weeks. Decrease in platelet count by 20-30% is the most
significant finding which begins to recover 3 to 4 days after donation. Long-
term follow-up studies have not suggested any increased risk of
haematological malignancy.31,50
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Complications due to central venous catheter placement due to poor
peripheral venous access (up to 20% of donations) include pneumothorax,
haemorrhage and infection but are uncommon. Complications of G-CSF
administration include precipitation of sickle crisis (in sickle cell anaemia or
complex sickle cell haemoglobinopathy patients), flares of autoimmune
disorders like rheumatoid arthritis and ankylosing spondylitis, inflammatory
conditions of the eye (marginal keratitis, episcleritis and iritis), increase in
spleen length and width or rarely, spontaneous splenic rupture. Anaphylaxis
to G-CSF has been documented and the risk is said to be 1 in 10, 000. G-CSF
administration is contra-indicated in pregnant women.
The risk of death does not appear to be higher than with marrow
donation. The few deaths which have been reported were due to hemothorax,
sickle crisis, stroke and cardiac arrest. In many of these donors, pre-existing
medical conditions were identi?ed post-mortem.31,50
Psychosocial effects of HSC donation
Donors who have undergone HSC donation were reported to be
generally positive about the donation one year later; 87% of them considered
the donation "very worthwhile". Donors with longer collection times, had less
positive psychosocial outcomes and those donors who experienced lower
back pain or difficulty walking were more likely to experience the donation as
more stressful and painful than expected.18
20
HISTOCOMPATIBILITY IN ALLOGENEIC HSCT
Genetic polymorphism of the HLA system is the most important
barrier in allogeneic HSCT.55 The HLA system is paramount with regard to
graft rejection and graft-vs-host disease (GVHD).56
The HLA System
Historical Aspects
In 1952, the existence of white cell antigens was first suggested and in
1958, leukocyte antibodies were identified by Jan Dausset and Payne, through
independent studies in the serum of multiply-transfused and in postpartum
women, respectively.57 The term “HLA” was derived by combining the
human-1 (HU-1) and leukocyte antigen (LA) designations used by them,
respectively, to describe the newly discovered leukocyte antigen system.58
Genetics of HLA system
A series of closely linked genes at position p21.3 on the short arm of
chromosome 6 56 constitute the Human leukocyte antigen (HLA) or Human
major histocompatibility (MHC) complex.58
Fig. 1: Human Major Histocompatibility complex (MHC) 110
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The Class I region consists of classical and non-classical genes. The
classical genes (HLA-A, -B and -C) encode Class I antigens. The non-classical
genes (HLA-E, HLA-F, HLA-G, HLA-H, HFE, HLA-J, HLA-K, HLA-L, MICA
and MICB) are expressed at lower levels and appear to have more limited
functions in the immune system. The Class II region consists of HLA-DR,
HLA-DP, HLA-DQ loci that encode Class II antigens. Several ?-chain loci
and one ?-chain locus encode the HLA-DR antigens. The DRB1 locus is
responsible for the DR1 to DR18 speci?cities, whereas the DRB3, DRB4, and
DRB5 loci are responsible for the DR52, DR53, and DR51 speci?cities,
respectively. The DQA1 and DQB1 loci encode the HLA-DQ speci?cities.
The genes DPA1 and DPB1 encode the HLA-DP speci?cities. Several
pseudogenes and genes with important accessory functions to Class I and II
antigen presentation are also present in this region. The Class III region is not
part of the HLA system and is located between Class I and Class II region.
56,57
Structure of HLA antigens
HLA antigens are cell-surface globular glycoproteins.59 The Class I and
II HLA antigens differ not only by gene locus but also by function, tissue
distribution and biochemistry.56
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Fig.2: Schematic diagram of HLA molecules. PBS
(peptide-binding site)110
Class I HLA antigens
HLA -A, -B and -C antigens have a molecular weight of about 57,000
Daltons and are found on platelets and most nucleated cells of the body
except neurons, corneal epithelial cells, trophoblasts and germinal cells . They
are made up of two types of chains linked by non-covalent bonds. The heavy
chain is an integral membrane protein and its external portion contains ?1, ?2
and ?3 domains. The ?1 and ?2 domains contain the majority of polymorphic
regions that confers serological antigen specificity. The light chain (i.e., ?2
microglobulin) is encoded by gene in chromosome 15. 56
Class II antigens
HLA-DR,-DQ and -DP antigens have a molecular weight of 63,000
Daltons and are expressed constitutively on B lymphocytes, monocytes,
macrophages, dendritic cells, intestinal epithelium, endothelial cells of
microvasculature, activated T lymphocytes and early hematopoietic cells.
They are made up of two integral membrane proteins, alpha and beta. The
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outermost portion of the molecule (alpha 1 and beta 1) contains the variable
regions. The outermost domain of the HLA molecules containing the
antigenic epitope, forms the “peptide-binding groove”. Alleles defined by
HLA gene polymorphisms encode unique amino acid sequences forming
unique binding grooves that bind to unique peptide sequences. 56
Functions of HLA system
T lymphocytes interact with peptide antigens only when they are
presented in the context of an MHC molecule (Class I for CD8 and Class II
for CD4 T lymphocyte), a process called “MHC restriction”.56 The HLA
system is important for self/non-self discrimination. Recognition of HLA
allelic differences between the donor and recipient by T lymphocytes confers
a higher risk of acute graft-versus-host disease and mortality in allogeneic
HSCT.60
Nomenclature of the HLA system
a. HLA antigens
Each serologic speci?city is pre?xed by the genetic system designation
HLA-, followed by a letter denoting the encoded antigen (e.g., A, B, C, DR,
or DQ) and then, a digit indicating the speci?city.57
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b. HLA alleles
For Class I alleles, because only the ? chain is variable, the molecular
designation is the system (HLA-), the locus (A, B, or C), an asterisk (?),
followed by up to four sets of digits separated by colons. All alleles receive at
least a four-digit name. The ?rst set of digits corresponds to the serologic
speci?city. The third and fourth sets of digits are employed to designate
alleles with silent polymorphisms or with variation occurring outside exons.
In the Class II region, the locus designation includes the polypeptide chain
responsible for the allele.57
Inheritance of HLA system
HLA genes follow Mendelian pattern of inheritance and are autosomal
and codominant. They are inherited in units known as haplotypes. Every
person has two HLA haplotypes, one from each parent. The phenotype is the
combined expression of both haplotypes. Inspite of linkage, crossover can
happen during meiosis at a low rate leading to new haplotypes in the
offspring. 56,57
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Fig. 3: Mendelian inheritance of HLA haplotypes demonstrated in a
family study110
Polymorphism of HLA genes
HLA system is the most polymorphic genetic system in humans. HLA-
A,-B, and -C loci are all highly polymorphic, with 2800 to 4100 known
alleles. HLA-DRB1 locus is highly polymorphic, with more than 1800 known
alleles. The other Class II region loci have similar but less extensive
polymorphism. The exons in which most of the polymorphism in the Class I
(exons 2 and 3) and Class II (exon 2) genes occurs encode the outermost
domains. New alleles emerging due to events like point mutation can become
?xed in populations. Due to linkage, many haplotypes are overrepresented
compared with what would be expected by chance in view of its polymorphic
nature. This is called “linkage disequilibrium” and it makes ?nding HLA-
identical individuals within a population possible for unrelated HSCT. HLA
allele and haplotype frequencies exhibit ethnic variation. 56,57
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HLA typing for HSCT
DNA-based methods like sequence-specific oligonucleotide probe
hybridization, sequence-specific primer polymerase chain reaction, sequence-
based typing and next-generation sequencing are used for typing of HLA
alleles for HSCT.57
Various levels of resolution of HLA typing are 55
a. Low resolution typing - the alleles are designated by ‘first-field level’
i.e., the two digits preceding the first separator. It is also called
“antigen level typing”
b. Intermediate resolution typing - the alleles are defined at the
‘second-field level’.
c. High resolution typing - the alleles are designated by ‘second - and
third -field level’ names (i.e., ?2 digit numbers preceding, respectively,
the second and third separators).
d. Allele level typing - refers to the unique nucleotide sequence for a
gene. Alleles are designated by using all digits in the first, second,
third and fourth fields.
27
HLA MATCHING IN ALLOGENEIC HSCT
In allogeneic HSCT, HLA typing is done to determine
histocompatibility between a donor and the recipient.4 HLA matching is based
on exons 2 and 3 polymorphism for class I loci and on exon 2 polymorphism
for class II loci.61 A “matched” donor may be defined on the basis of high-
resolution allele definition at four loci-HLA-A, B, C, DRB1 (“8/8”) - or five
loci - HLA-A, B, C, DRB1, DQB1 (“10/10”)62 and more recently, at HLA-
DPB1 locus additionally(“12/12”).4,55
HLA matched sibling donor
HSCs are collected from a HLA-identical sibling of a patient.35 The
probability of identifying such a donor depends on the number of siblings.
The chance of a patient with “n” siblings having at least one HLA- identical
sibling is 1 – (3/4) n and is 25% for patients with one sibling. Thus, having
two siblings provides a 44% chance, and having three siblings provides a 58%
chance, 68% for those with four and up to 90% chance for those with eight
siblings.55 Every time a new sibling is tested, that new sibling has only a 25%
chance of being a match.56
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Matched unrelated donor (MUD)
HLA-genotypically identical sibling donors are the gold standard for
allogeneic HSCT55 since such they are identical not only for the
polymorphisms detected by HLA typing but also for all other polymorphisms
in the MHC complex.60 However, only 30% patients have such a donor.55
Small family size is one of the major limitations in finding HLA-matched
sibling donors63 and those lacking a sibling donor must seek donations from
unrelated persons in the general population.3 In the context of unrelated
individuals, matching is defined only with respect to the polymorphisms
encompassed by the testing.60 HSCT using such donors is of the greatest
benefit to the recipients if performed when the leukemic burden is lowest and
when the procedure can be tolerated.62 The probability of identifying a
matched unrelated donor depends upon the ethnic origin of patients and on the
matching grade required by the transplant centre.55 The availability of donors
for unrelated allogeneic HSCT is made possible by the establishment of
registries.64
UNRELATED HSC DONOR REGISTRY
A registry is a national organization whose responsibility is to process
requests for unrelated donors of HSCs65 Its major goal is to create a ?le of
well-informed and well-selected volunteers, with the greatest likelihood of
being suitable donors if chosen for speci?c patients.66 The registry has a fixed
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physical location67 and is a legal entity or is contained within a legal entity
operating within the country to which it belongs.68 The registry coordinates
the activities of Donor, Collection, and Transplant Centres in the respective
country.65
Historical aspects
In 1971, a child named Anthony was born in United Kingdom with
Wiskott–Aldrich syndrome. His only hope for cure was bone marrow
transplant but he did not have HLA-matched donors within his family. In
1973, the first successful unrelated donor transplant was performed on a child.
This gave Anthony’s mother, Shirley, an idea that would benefit all patients
who desperately needed an unrelated donor. In 1974, she started the Anthony
Nolan Bone Marrow Register in Westminster Children’s Hospital, where
Anthony was a being treated.69 The HLA type of volunteers was recorded and
listed in an accessible format in the event that the donor’s type might match
that of a patient in need of a transplant.14,64 Though the register grew
throughout the seventies, it couldn’t help Anthony Nolan who died in 1979.
However, it paved the way for similar projects in the United States and
worldwide.64
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Fig. 4: Worldwide location of unrelated donor registries64
(Star symbol indicates location of registries)
In 2010, there were a total of 9 unrelated HSC donor registries in North
America, 47 in Europe, 2 in Africa, 11 in Asia, and 2 in Australia.64 The
National Marrow Donor Program (NMDP) in the United States and Zentrales
Knochenmarkspender Register Deutschland (ZKRD) in Germany list more
than 1 million volunteer donors.70 The largest bone marrow registries in Asia
are in Japan and Taiwan.3 In 2012, the German registry Deutsche
Knochmarkspenderdatei (DKMS) set the Guinness World Record for the
most bone marrow donors (2,976) recruited in 24 hours. 71
Unrelated HSC Donor Registries in India
In India, almost all the unrelated HSC donor registries are run by non-
governmental organizations. A proposal to create donor registry as part of the
National Health Mission is being evaluated by the Health ministry.72
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a. Asian Indian Donor Marrow Registry (AIDMR)
AIDMR was launched in 1994 in association with Dadhichi Deh Dan
Samiti at the All India Institute of Medical Sciences, Delhi.10 It is the first and
the oldest registry in India6 and also the first-of-its-kind initiative by any
public hospital in the country.73 It has about 3925 registered donors and
gained impetus when it was relaunched in August 2014.10
b. DATRI Blood Stem Cell Donors Registry
DATRI is a not-for-profit organization set up in 2009 by Mr. Raghu
Rajagopal, along with HLA typing experts Dr. Nezih Cereb and Dr. Soo
Young Yang.6 It facilitated India’s first voluntary peripheral blood stem cell
donation in April 2011 by Mr. Ajit Kumar Das from Odisha.11 It is actively
involved in organizing regular campaigns and recruitment drives across the
country.12 It has become the largest registry in India with more than 1,22,150
registered donors from various ethnic backgrounds.11,12 It has facilitated 150
donations as of March 2016.12 It is a member of World Marrow Donor
Association and is also registered with Bone Marrow Donors Worldwide
(BMDW).74
c. Marrow Donor Registry (India) [MDR (I)]
MDR (I) was launched at Tata Memorial Hospital, Mumbai, with
haematologist Dr Sunil Parekh as its founding member and chairman. From a
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mere 889 donors in 2009, the registry size has grown to more than 25,000
registered donors as of May 2015.75 MDR (I) launched its Gujarat chapter in
July 2014 along with Indian Red Cross Society and Gujarat Cancer
Hospital.76 MDR (I) is registered with BMDW.1
d. “Life de India” Stem Cell Registry India (SCRI)
Bangalore Medical Services Trust, a not-for-profit organization of the
Rotary Club of Bangalore and TTK group of companies, started the “Life de
India”, Stem Cell Registry India (SCRI) project in 2009 with an aim to
motivate voluntary blood donors to register as potential bone marrow donors.
More than 5000 have joined the registry.77
e. Bharat Stem Cell Registry
Bharat Stem Cell registry was set up in 20126 and has its base in Delhi.
It is an initiative of Safe Blood Organisation, a non–profit organisation.78 It
has 3,500 registered donors as of July 201513 and is registered with BMDW.1
f. Jeevan Stem Cell Registry
It was launched in May 2015 by Jeevan Blood Bank and Research
Centre in Chennai with a target of recruiting 50,000 donors over a five-year
period from a pool of voluntary donors across the country who have donated
blood or platelets twice in the previous two years.79
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g. BMCDT Bone Marrow Registry
The Bangalore Medical College Alumni Association formed The
Bangalore Medical College Development Trust (BMCDT) in May 2015 with
an aim to enrol donors through its bone marrow registry committee. Within
three weeks of its launch, around 100 donors were registered after conducting
awareness drives in Bangalore.80
STRATEGIES TO RECRUIT AN UNRELATED DONOR
Joining the registry implies a general offer to be available for any
patient in need of a HSCT anywhere in the world, irrespective of the patient’s
age, gender, nationality, creed or ethnicity.81 The minimum age to join the
registry is as per the national laws governing general anaesthesia and blood
donation or is 18 years of age, if no such regulations exist. The maximum age
is as per the policy of the registry and should not exceed 60 years after which
donors will be removed from the registry.67 Donation of HSCs is not
remunerated but incurred expenses may be reimbursed.81 The decision to join
the registry is the individual choice of the adult donor.50 The decision to
proceed to donation after being confirmed as a match is also purely voluntary
and non-remunerative. Identity of both the donor and patient is kept
confidential during the entire search and donation process allowing the donor
to make an unbiased decision. However, the volunteer donor has the right to
withdraw at any stage.81 In terms of risks and inconveniences to the donor,
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HSC donation is placed on a middle ground between blood donation and
living solid organ donation. Considerable time gap (~ 8 years) may occur
between recruitment and identification as a potential match and repeated
donations may be requested for a patient. The donors may forget that they had
registered earlier or refuse to donate or refuse repeated donations.82 Valid
written consent obtained after providing information in a graded manner at
each stage solicits a graded commitment from the donor.81 Strategies for
recruitment of an unrelated donor takes into account the particularities of
HSC donation.82
Target group for recruitment
Early strategies targeted HLA-typed platelet donors. However, family
members of bone marrow transplant recipients, regular blood donors19 and the
general public83 became subsequent targets for recruitment. Young donors are
targets to the registry because they remain in the registry for a longer
duration84 and also due to evidence indicating more favourable transplantation
outcomes for transplants using younger donors.85
Types of donor recruitment drives
The types of donor drives are 83
a. Family drive - initiated by a person with a family member who needed
a HSCT.
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b. Minority drive - initiated by a family but aimed at recruiting potential
donors who are members of a specific minority group.
c. Organization drive - initiated by corporations, community service
groups or units of government.
Place of recruitment
In many registries, an established structure called the “Donor Centre”
is responsible for recruitment of prospective donors65 It is often a blood bank
or a transfusion centre, but it can be any suitable organisation. Recruitment is
also organised at external sites where health history questionnaires are filled
out and blood/buccal swab samples collected. Alternatively, potential
volunteers are also counselled over phone and then directed to a specific
hospital for giving samples.17 Online registration of volunteers is also
available.74
Medium for motivation
Printed material (lea?ets, posters, etc.), media (radio, TV, newspapers,
magazines), verbal presentations, information on telephone lines and videos,
electronic mail, the world wide web are utilized for making rational or
emotional appeals to potential volunteers.81,86 Celebrities have also been
identified by certain registries as Brand ambassadors to promote motivation.76
The third Saturday of September has been officially declared as “World
Marrow Donor Day” since 2016. It is celebrated in 52 different countries
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throughout the world with the aim of raising awareness among the general
public and decision-makers about being a stem cell donor and the impact of
blood stem cell transplantation on patients’ lives.87
Support from the Government
Leave and/or tax benefits for HSC donors and financial support to the
registry have been demonstrated to have a positive effect on HSC donation
and are crucial for enhancing HSCT programs.88
DONOR MEDICAL SUITABILITY
Medical evaluation of a donor is done is to identify those conditions
that may increase the risk to either the donor or the recipient. HSCT has the
potential to transmit the same range of blood-borne infections as blood
transfusion. Certain hematological malignancies, autoimmune and inherited
conditions have also been reported to be transmitted through HSCT.31 The
intensity of the assessment differs at each stage. The donor has the right to
receive the results of medical assessment.67
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Table 1: Conditions leading to permanent deferral of unrelated HSC
donor66
Systemic Hypertension ( systolic >
180 mm Hg or diastolic > 100 mm
Hg
Asthma
Intervertebral disc problem
Malignancy (current/past)
Chronic inflammatory diseases
History of cerebrovascular diseases,
Haemophilia, von Willebrand
disease,
Mental health problems
Drug abuse
Diabetes mellitus, glaucoma
History of coronary disease, angina
pectoris, severe cardiac arrhythmia
Latex allergy
Serious liver disease , Cirrhosis or
Wilson's disease
Solid organs or HSC transplantation
Systemic autoimmune diseases
History of severe trauma of head and
central nervous system
 Infections (Babesiosis, Chaga’s
 disease, Creutzfeldt-Jakob disease,
 HTLV I/II infections, Leishmaniasis ,
 Leprosy, Chronic Lyme disease,
 meningitis, Q fever, Typhus,
 Hepatitis B and C virus , HIV
Table 2: Conditions leading to temporary deferral of unrelated HSC
donor66
Endoscopy with biopsy using flexible
instruments
Epilepsy
Fever above 38 °C
flu-like illness
Kidney disease/acute
glomerulonephritis
Medication
Piercing (body, skin, ear)/ Tattoo
Pregnancy/abortion
Rheumatic fever
Surgery
Blood Transfusion
Prophylactic immunizations with
attenuated bacteria and viruses
Infections (Malaria, Osteomyelitis,
Syphilis Tropical diseases,
Tuberculosis, Brucellosis,
Toxoplasmosis)
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SEARCH FOR AN UNRELATED DONOR IN THE REGISTRY
The process of identifying a suitable unrelated donor to donate HSCs
for a patient in need of transplant is called “search”.89 The donor selection
criteria like donor age, gender, HLA compatibility etc., is determined as per
the protocol of the requesting transplant centre.90 The registry responds to the
request and facilitates the process using search algorithms like OptiMatch,
HapLogic incorporated as the key element into its software system. A list of
potential donors is provided with the donors most likely to be an optimal stem
cell source for the patient present at the top of the list. 91
Fig. 5: Basic concept of the donor search algorithm91
“Preliminary search” identifies the presence or absence of potential
matched donors so that a decision to go ahead with transplantation can be
made. A “formal search” is when the transplant physician requests additional
HLA typing on the potential HLA-compatible donors identi?ed during the
preliminary search process and receives results of the same.90
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Fig. 6: Flow diagram showing the steps of the search process70
PATHWAY OF AN UNRELATED HSC DONOR
There are three stages in the typical pathway of an unrelated donor
from the time of registration until donation of HSCs.31
1. Recruitment stage
This is the first stage wherein persons willing to donate HSCs to any
person anywhere in the world volunteer to get registered in the Registry.
a. Information to the donor
Written information is given to the donor regarding principles,
procedures, restrictions and risks of providing blood and other samples and
haematopoietic stem cells (either via marrow or peripheral blood donation). It
is informed that donation will not take place immediately and further blood
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samples may be requested at any time in future. Also, during search requests,
medical information like HLA type, infectious disease marker (IDM) test
results, blood group, rhesus type, relevant medical history will be provided to
transplant centres along with a unique donor number but personal data will be
kept strictly confidential. It is informed that the donor has the right to
withdraw from the Registry at any stage. The Registry should be notified of
changes including commitment to remain on the Registry, contact information
and medical status like pregnancy or other conditions that may preclude
donation temporarily or permanently.81
b.  Medical evaluation of donor
The goal of assessment at this stage is to exclude those with medical
conditions or lifestyles that would permanently preclude donation. The
minimum donor information required at this stage includes height, weight,
past or current medical problems, history of allergies, malignancy ,
autoimmune diseases, high-risk sexual behavior, infections [Human
Immunodeficiency Virus, Hepatitis B , Hepatitis C, Human T-lymphotropic
Virus, Syphilis , Creutzfeldt-Jakob disease , Chagas disease, tuberculosis,
malaria], inherited conditions (sickle cell disease, thalassemia, bleeding
disorder) current medications, non-prescription parenteral drug use.31
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c.   HLA typing
It is performed on buccal swabs or blood samples 92,93 and consists of
atleast low-resolution typing of HLA-A,-B,-DR loci.94
All donor-related information like contact details, age, gender, medical
status etc., are uploaded into the software system of the Registry along with
the unique donor number assigned to the eligible donor.67
2. Confirmatory/Verification Typing (CT/VT) Stage
When a potential donor/recipient match is identi?ed following a search
request, the donor is contacted to obtain a sample for con?rmatory HLA
typing and infectious disease marker (IDM) testing.31 The donor is reserved
for a given patient after donation of tissue samples and is excluded from other
patient searches.92
a. Information to the donor
Information is given by a trained and quali?ed representative of the
donor centre. Donors are reminded of the procedures, restrictions and risks
associated with stem cell donation as a considerable duration may have
elapsed from the time of recruitment and also because of the likelihood of
progression to donation.31 It is informed that blood samples will be obtained
for histocompatibility testing, testing for infectious disease markers and other
relevant analyses. The current probability of being selected for a particular
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patient is informed. Travel to another country is not necessary in the event of
donation to a recipient from a foreign country. The possibility of further
donation requests following initial donation is discussed brie?y. Suf?cient
time is provided to the potential donor to clarify queries.81
b. Medical evaluation of donor
Before obtaining samples for IDM testing and confirmatory HLA
typing, further medical information like history of acute or chronic back pain,
systemic hypertension, cardiac disease, asthma, epilepsy, pregnancy, blood
transfusion, alcohol consumption etc., is elicited from the donor and any
condition that suggests an increased risk to the recipient is reported to the
transplant centre in order to determine suitability of the donor.31
c.  HLA typing
High-resolution typing of HLA loci is performed which is required for
matching with the patient.61 ABO and Rh type is also tested, if not done
previously.67
3.  Work-Up Stage
At this stage, a volunteer has been identi?ed as a match for a patient
and is medically evaluated for ?tness to donate hematopoietic stem cells after
giving consent for the same.65
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a. Information to the donor
In a face-to-face interview by a trained and quali?ed medical doctor, it
is informed that the volunteer has been considered a match for a particular
patient and is requested to donate. The volunteer’s right to decline (even
while the patient is being conditioned92) and its consequences are informed. A
comprehensive overview of the entire process is given including the purpose
of medical assessment, donation methods with their respective advantages and
disadvantages, the possible need for autologous or allogeneic blood units and
associated risks, post-donation recovery. The ?nal choice of route of donation
is with the donor. The probability of successful treatment of the patient and
postponement or cancellation due to changes in the medical condition of the
patient is discussed. Willingness to make further donations for the same
patient is enquired. Other issues like insurance coverage by the registry,
monitoring of the donor post-donation are discussed.81
b. Purpose of Medical Evaluation
Evaluation of the donor at this stage is an opportunity for thorough
assessment to identify any medical condition that might have been missed at
an earlier stage. A travel history is obtained to prompt appropriate testing. An
in-depth sexual history is obtained to identify the possibility of an increased
risk of transmission of blood-borne infections.31
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Table 3: Investigations at workup stage31
Examination
General (including height and weight); cardiovascular
(including blood pressure); respiratory; gastrointestinal;
neurological
Haematology
Biochemistry
Full blood count; coagulation screen (including Prothrombin
Time, Activated Partial Thromboplastin Time and
fibrinogen); Erythrocyte Sedimentation rate; peripheral
smear; haemoglobin electrophoresis or high-pressure liquid
chromatography ,if indicated
Urea and electrolytes; liver function tests; Lactate
dehydrogenase ; ferritin; random glucose; ?-HCG (for
females of child-bearing age)
Other
investigations
Chest X-ray; electrocardiogram
Table 4: Minimum recommended donor infectious disease marker
testing31
Stage Infectiousdisease Recommended validated assay
Recruitment Nil Nil
CT/VT
stage HIV HIV-1,2 antibody
Hepatitis B Hepatitis B surface antigen
Hepatitis C Hepatitis C antibody
Work-up HIV HIV-1,2 antibody, p24 antigen, HIV RNA
Hepatitis B
Hepatitis B surface antigen and antibody
Hepatitis B core antibody, hepatitis B
DNA
Hepatitis C Hepatitis C antibody, hepatitis C RNA
HTLV I+II HTLV I+II antibody
Syphilis Validated serological testing algorithm
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Part or whole of the evaluation may need to be repeated when there is a
delay in transplantation.
Table 5: Schedule of testing in the event of delay in collection of HSCs31
Time from work-up
medical assessment to
collection date
Repeat assessments required
30 days None
>30 days, 90 days Infectious disease markers only
>90 days, 12 months
Donor history and examination, all laboratory
tests excluding hemoglobinopathy screening,
Infectious disease markers
>12 months
Donor history and examination, all laboratory
tests excluding hemoglobinopathy screening,
Infectious disease markers
Chest X-ray and ECG
Psychological assessment of the donor
The psychological condition of the donor should be assessed to
determine the motivations for considering the HSC donation and to rule out
any coercion on the donor.50 After HSC donation, the donor is reserved for
that particular patient. During this period, the donor may donate whole blood,
plasma, and platelets for the public domain, according to national blood-
transfusion standards.92
46
DONOR FOLLOW-UP AFTER HSC DONATION
Donor follow-up is conducted within the ?rst week of donation, at 1-
month post donation (or until resolution of all symptoms is reported), at 1
year and thereafter annually or bi-annually for up to 10 years (lifelong in
some countries).95
SUBSEQUENT DONATION AFTER INITIAL HSC DONATION
About 5–10% of the donors are requested for a subsequent donation of
HSCs or Therapeutic cells (TCs) [T lymphocytes, whole blood, platelets etc.,]
for immune modulation or to increase donor-derived haematopoiesis. The
most common subsequent donation is donor lymphocytes, followed by
PBSCs, bone marrow and whole blood.95 Second donations of HSCs are not
associated with an increased risk of donor complications but the yield of
CD34+ cells may be lower in some donors. Short intervals (< or =3 months)
between donations requires limited evaluation including a full blood count
and tests for mandatory infectious disease markers. Longer intervals warrant
full medical evaluation. A minimum period of 4 weeks should elapse between
the ?rst and second donations of HSCs.32 Donors can donate HSCs for a
maximum of two patients, with rare exceptions. The minimum duration
between donations to two patients is 12–24 months except when the first
recipient has died. Two or more further HSC donations for the second patient
may occur but there are no recommendations as to how many donations of
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bone marrow versus PBSC should be allowed. One donation of TCs is
routinely accepted. Second donations of TCs to the same recipient depends
upon Registry policy and the minimum interval is about 1 to 3 months. TCs
are not donated to a patient for whom the donor has not donated HSCs. If the
donor who has donated to an unrelated person is later asked to donate for a
family member, eligibility of the donor to donate and to remain available on
the unrelated registry needs evaluation.95
ACCESS TO INTERNATIONAL DONORS OF HSCs
About one-third of unrelated transplantations worldwide utilize HSCs
from a donor in another country.65 Exchange of HSCs is permitted in India.96
In 2013, 52 of the 76 HSC products were from unrelated donors of other
countries i.e., 29 (38%) came from Germany, 17 (22%) from the USA and 6
(8%) from other countries.22 The concept of unrelated HSC donor search at
the international level was initiated by Jon J van Rood at the Europdonor
Foundation in Leiden. The global catalogue of HLA phenotype data came to
be known as Bone Marrow Donors Worldwide (BMDW).64 Currently, 75
individual national registries from 53 countries are registered members of
BMDW and have pooled their HLA donor data into its multi-national
database.1
The World Marrow Donor Association (WMDA) is an international
non-pro?t organization founded in 1994 in Netherlands.64 It promotes the
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de?nition and standardization of ethical, technical, medical, and ?nancial
aspects of HSCT involving volunteer donors in one country who give HSCs
to unrelated patients in another country.65 Its mission is to foster collaboration
between international registries and to ensure that high-quality products are
available for all patients while maintaining donor health and safety.31,64
NEED TO INCREASE THE SIZE OF THE REGISTRY
About 28 million people have registered as HSC donors worldwide.1
However, this represents only about 0.3 % of the world population.4 HLA
genes are highly polymorphic; more than 14,000 HLA alleles have been
assigned which accounts for more than 10,000 different HLA proteins.55 Also,
allelic variation is population-speci?c.5 This increasing level of complexity
has negative consequences for patient/unrelated donor matching.55 Two
people are more likely to match if they belong to the same race.3 The amount
of representation of a particular ethnic or racial group in a registry is very
important.4 Other factors like low intra-population genetic diversity and close
genetic relatedness to other donor populations available in the registry also
increase match likelihoods.22 About 1-5% of patients do not have a single
potentially matched donor in the BMDW database since majority of the
donors represent Western European ancestry.55 Total Asian population is only
11 % of the total number of registered donors worldwide.4
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India is a land of ethnic, cultural, geographic and linguistic diversity
reflected by the existence of 3824 castes, 25,000 sub-castes and 461 tribes.97
Novel HLA alleles and unique haplotypes have been detected in the Indian
population.63 The probability of an Indian patient ?nding an allele match is 16
% in multinational registries and even lesser (only 0.008 %) in the India given
its current registry size (~ 1.5 lakh donors in total).4 Thus, Indian patients are
more likely to find a match outside of the country than within.5 However,
relying on foreign registries is time-consuming, costly (~12 lakh rupees for
search process alone14) and may not be productive at all times. A population-
based study modelled Indian registry growth to predict the likelihood of
identifying a suitable donor. It was found that the mean proportion of
individuals who would have a 10/10 adult donor match within India would be
28·1% with a registry size of 1 lakh. The proportion of matches increased
logarithmically with increased registry size. Also, only when it increased to
2.5 lakh did the match rate within India exceed that found by searching a
foreign registry combined with the national registry.5 Thus, there is an
obvious need to increase the registry size in India.
JOINING UNRELATED HSC DONOR REGISTRY
A study on motivation behind donating HSCs to an unrelated person
identified different motives like a desire to act in accordance with social or
religious precepts, expected positive feelings about donating, empathy for the
recipient, simple desire to help another person, and exchange motives.98 Yet,
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the first step in unrelated HSC donation is voluntary enrolment of the donor
into the registry.
KNOWLEDGE, ATTITUDE AND BEHAVIOUR (KAB)
As per KAB model, knowledge is a prerequisite to the intentional
performance of a health-related behaviour.23 Various studies have reported
about awareness and knowledge regarding HSC donation and unrelated HSC
donor registry.
Varghese ST et al99 in their study among 81 engineering students in
Kerala found that 18.5% of the students were aware about HSC donation.
Further, 69.1% of them had inadequate knowledge, 30.9 % of them had
moderately adequate knowledge and none of them had adequate knowledge
regarding HSC donation. Laver JH et al100 in their study among 589 potential
eligible HSC donors in South Carolina in 2001 found that 92% were aware of
HSCT as a life-saving procedure and 51.7 % of them were aware of their
national HSC donor registry. Onitilo AA et al101 in their study in South
Carolina in 2004 among 829 potential eligible HSC donors found that 92.8%
of them were aware of HSCT as a life-saving procedure and 42.9% of them
were aware of their national HSC donor registry.
The KAB model also states that information leads to accumulation of
knowledge which changes attitude, behaviour, or both.23 Extrapolating the
theory of reasoned action and the theory of planned behaviour, the act of
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joining a registry must be preceded by the intention to do so which is
measured by seeking an estimate of the probability of acting on that speci?c
behavior.26 Kaya Z et al102 in their study on 301 college students in Turkey in
2015 reported that before and after lecture, 65% and 76% of them were
willing to donate HSCs, respectively. Studts JL et al86 in their study among
102 medical students in Kentucky reported that 49% of the participants
agreed to register at an unrelated HSC donor registry after providing
necessary information with regard to HSC donation.
Not all the individuals who were willing to donate HSCs to unrelated
individuals, were willing to join the registry. Kwok J et al88 in their study
among 3479 potential HSC donors in Hong Kong found that among those
who were willing to donate HSCs to unrelated individuals, 51.5% of them
were willing to be contacted to sign up for their national registry and Onitilo
AA et al101 in their study found that only 44.7% of those who were willing to
donate HSCs, were willing to be contacted to sign up for the national registry.
Individuals showed preference in their willingness to donate HSCs.
Sanavi S et al103 in their study among 416 Iranian high-school students
reported that among those who were willing to donate HSCs, 16 % of them
wanted to donate only to their family members and Kwok J et al88 in their
study reported that among those who were willing to donate HSCs, 25.5% of
them expressed willingness to donate only to their family members.
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Reasons for unwillingness of the individuals to donate HSCs have been
reported in various studies. Kwok J et al88 in their study reported that fear of
pain, fear of after-effects, health concern and inadequate knowledge were the
major reasons for unwillingness to donate HSCs. Onitilo AA et al101 in their
study reported that fear of pain, inconvenience, cost of being a donor, lack of
opportunity were the major reasons for not wanting to become a donor of
HSCs.
Individuals’ willingness to donate HSCs have been found to be
influenced by others’ opinion. McCullough J et al104 in their study among 150
whole blood or apheresis donors in Minnesota in 1986 reported that 54% of
the donors had discussed with another person, most commonly the spouse,
before enrolling into unrelated HSC donor registry.
Studies have reported about individuals who had already exhibited
behaviour by joining a registry. The studies done among potential eligible
HSC donors by Kwok J et al88 and Bart T et al105 revealed that 13.6 % and
22.8%, respectively, were already registered at an unrelated HSC donor
registry.
Studies have also investigated various sociodemographic variables for
their influence in individual’s willingness to donate HSCs.
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Age
Volken T et al106 in their study among 900 potential eligible HSC
donors in Switzerland and Beatty PG et al19 in their study in 1989 in USA
found that age was not significantly associated with willingness to become a
donor of HSCs. However, in the study by Kwok J et al,88 it was reported that
respondents were more willing to donate to unrelated individuals if they were
in the age groups of 18-46 years. Onitilo AA et al101 also reported in their
study that younger individuals were more willing to donate HSCs.
Gender
Volken T106, Kwok J et al88, Onitilo AA et al101 and Beatty PG et al19
in their the studies reported that gender was not significantly associated with
willingness to donate HSCs. However, less male students showed intention to
donate HSCs than female students in the study by Kim M et al 107 in their
study in Korea among 174 nursing students. Also, Studts JL et al86 in their
study also reported that females were more likely to agree to register at an
unrelated HSC donor registry. However, Briggs et al108 in their study among
489 apheresis donors reported that women were less likely to express
willingness to donate HSCs than men.
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Marital status
Briggs et al 108 in their study showed that married people were less
likely to express willingness to donate HSCs than unmarried people.
However, Studts JL et al86 had reported in their study that married participants
were more likely to agree to register at an unrelated HSC donor registry.
Education
Volken T et al106, Sanavi S et al103 and Briggs et al108 in their studies
reported that education was not significantly associated with willingness to
donate HSCs. However, studies by Onitilo AA et al101, Kwok J et al88 and
Laver JH et al100 reported that individuals with higher levels of education
were more willing to donate HSCs.
Whole blood donation
Beatty PG et al19 in their study reported that there was a strong
correlation between previous blood donation history and probability of
becoming a donor of HSCs. Donors who had given 5 or fewer units in the past
5 years’ duration had a 5 percent probability of joining, donors who had given
between 16 and 20 units had a 38 percent probability, and donors with a
history of more than 20 units had a 60 percent probability of joining the
registry. In contrast, results of the study by Briggs et al108 showed that the
number of prior whole blood donations was negatively related to willingness
to become a HSC donor.
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Apheresis donation
Briggs et al108 in their study reported that prior apheresis donation was
negatively related to willingness to become a HSC donor.
Level of knowledge
Results of the study by Kwok J et al88 showed that level of knowledge
regarding HSC donation was significantly associated with willingness to
donate HSCs and higher knowledge scores were related to willingness to
donate HSCs.
Having a known person who needs HSCs as treatment
Galanis PA et al109 in their study in Greeks among 565 potential
eligible HSC donors reported that persons with a relative or a friend in need
of HSCT were more likely to express willingness to donate HSCs. Also,
results of the study by Studts JL et al86 showed that participants who had a
family history of cancer were more likely to agree to register as a donor of
HSCs.
Thus, KAB study among voluntary blood donors regarding HSC
donation and unrelated HSC donor registry would help in framing dedicated
initiatives to facilitate donor pool expansion in unrelated HSC donor registries
in the country.
MATERIALS & METHODS
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MATERIALS & METHODS
Study design
This study is a qualitative study conducted at the Department of
Transfusion Medicine, The Tamil Nadu Dr. M.G.R Medical University,
Guindy, Chennai. The University Ethical Committee of The Tamil Nadu Dr.
M.G.R Medical University approved this study.
Study population
Persons who fulfilled the eligibility criteria for blood donation as per
the guidelines of Directorate General of Health Services (DGHS)111 and who
donated blood (at camps and through “walk-in”) to the Blood Bank of the
Department of Transfusion medicine, The Tamil Nadu Dr. M.G.R Medical
University, Guindy, Chennai during the study period from July 2015 to June
2016.
Inclusion criteria
Voluntary blood donors who were willing to participate in the study
were randomly included.
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Exclusion criteria
Persons who did not fulfil the eligibility criteria for blood donation as
per the guidelines of DGHS and eligible voluntary blood donors who were not
willing to participate in the study were excluded.
Sample size
Sample size was calculated using nMaster Software as 384 with
expected proportion 50%, precision 5% and 95% confidence level, using the
formula:
(1.96)2 x p x q
n  = -------------------
           d2
Refusals and drop outs : 10 % (i.e., 38)
Minimum required sample size : 422
Statistical analysis
Data was entered into EXCEL and statistically analysed using SPSS
software. Categorical data was expressed in frequency and percentage. Chi
square test was used to assess the association between donor-related factors
and willingness to donate HSCs to unrelated individuals.
58
Materials
1. Donor-related data were collected including age, gender, marital
status, level of education as per Kuppuswamy scale,112 past history
of blood donation, number of units of blood donated, past history of
apheresis donation.
2. Pre- and post- interventional study questionnaire was used to
collect information about knowledge, attitude and behaviour among
voluntary blood donors regarding hematopoietic stem cell (HSC)
donation and unrelated HSC donor registry.
3. Assessment of knowledge, attitude and behaviour (KAB)
A. Knowledge:
Knowledge was assessed based on the response to the following 6
questions.
a. Have you heard about marrow stem cell donation?
b. Do you know for what purpose marrow stem cells are donated?
c. Is there any person known to you who needs or has needed
marrow stem cells as treatment?
d. Do you know about the risks involved in marrow stem cell
donation procedure?
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e. Do you know what important test is done before marrow stem
cells are donated?
f. Have you heard about registry for unrelated adult marrow stem
cell donors?
Each correct response was given one point. Score obtained by each
donor was calculated out of a total of 6 points. Level of knowledge
was categorised as given in the following table:
Score Obtained
(Maximum – 6 points)
Level of Knowledge
> 3 “Desirable”
? 3 “Below desirable”
B. Attitude
Attitude was assessed based on the response to following questions
regarding willingness to donate HSCs.
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Willingness to donate HSCs
Prior to providing information on
HSC donation and unrelated HSC
donor registry
After providing information on HSC
donation and unrelated HSC donor
registry
Yes No /Not sure
ReasonsTo whom HSC donation was
preferred
Change in decision to donate HSCs
based on others’ opinion?
Family Known
unrelated
person
Anyone
• Willingness to join
unrelated HSC donor
registry
• Willingness to donate HSCs
more than once
• Willingness to donate
blood/components after
initial  HSC donation
Yes No
Whose Opinion?
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C. Behaviour:
 Behaviour was assessed by registration status of voluntary blood
donors at an unrelated HSC donor registry.
Methodology
1. Persons who volunteered to donate blood at camps and also
through “walk-in” were made to fill Donor History
Questionnaire for blood donation and then undergo physical
examination by the Medical officer.
2. Once declared fit to donate blood, individuals were approached
randomly for their willingness to participate in the study after
explaining about the study and their informed consent obtained.
3. Participants were individually interviewed and pre-
interventional part of the questionnaire was completed.
4. Then, a handout  providing information as per guidelines of the
World Marrow Donor Association81 was given to the
participants, covering the following aspects:
a. About HSCs 113
b. HSC transplantation (HSCT) 113
c. Role of Human leukocyte antigen (HLA) in HSCT 2,113
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d. HSC donation 81,50,113,114
e. Unrelated HSC donor registry 11,75,81
f. Need for more unrelated HSC donors in India 5,8,14,16,55
5. The interview was continued and the post-interventional part of
the questionnaire was completed.
6. The participants were thanked and then directed to the
phlebotomist.
RESULTS
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RESULTS
I. STATISTICS ON DONOR-RELATED DATA
1. Age distribution of voluntary blood donors
Variable Minimum Maximum Mean Std. Deviation
Age (years) 18 57 25.22 7.76
18-24 25-44 45-60
No.of donors 262 146 14
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Age distribution of voluntary blood donors
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2. Gender distribution of voluntary blood donors
3. Marital status of voluntary blood donors
95.3%
4.7%
Gender distribution of voluntary blood donors
Male(n= 402)
Female(n= 20)
74.2%
25.8%
Marital status of voluntary blood donors
Unmarried(n=313)
Married (n= 109)
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4. Education of voluntary blood donors
5. Blood donation status of voluntary blood donors
Illiterate PrimarySchool
Middle
School
High
School
High
School
Diploma
Graduate
or Post
Graduate
No.of donors 1 1 11 34 205 170
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Education
Education of voluntary blood donors
41.2%
58.8%
Blood donation status of voluntary blood donors
First-time donor (n=174)
Repeat donor (n=248)
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6. No. of blood units donated in repeat voluntary blood donors
Variable Minimum Maximum Mean Std. Deviation
No. of blood units
donated previously
in repeat donors (n=248)
1 130 4.86 9.536
6. Past history of apheresis donation in voluntary blood donors
In this study population (N= 422), 7 (1.7%) donors had undergone
plateletpheresis.
<  5 > 5
No.of donors 187 61
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No.of blood units
No. of blood units donated in repeat voluntary
blood donors
98.3%
1.7%
Past history of apheresis donation in voluntary blood
donors
No (n = 415)
Yes (n = 7)
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II. STATISTICS ON KNOWLEDGE
1. Awareness about HSC donation in voluntary blood donors
In this study population (N = 422), 68 (16.1%) donors were aware of
HSC donation.
2. Awareness about unrelated HSC donor registry in voluntary blood
donors
In this study population (N = 422), 10 (2.4%) donors were aware of
unrelated HSC donor registry.
83.9%
16.1%
Awareness about HSC donation in voluntary blood donors
Not heard about HSC
donation (n=354)
Heard about HSC
donation(n=68)
97.6%
2.4%
Awareness about unrelated HSC donor registry in voluntary
blood donors
Not heard about unrelated
HSC donor registry (n =
412)
Heard about unrelated
HSC donor registry (n= 10)
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3. Assessment of level of knowledge regarding HSC donation and
unrelated HSC donor registry among voluntary blood donors
Variables No. of donors Percentage
Heard about HSC donation Yes 68  (out of 422) 16.1%
No 354 (out of 422) 83.9%
Knows about purpose of HSC
donation
Yes 34 (out of  68) 50%
No 34 (out of  68) 50%
Any person known to the donor
needing HSCs as treatment
Yes 7 (out of  34) 20.6%
No 27 (out of  34) 79.4%
Knows about risks involved in HSC
donation
Yes 3 (out of  68) 4.4%
No 65 (out of  68) 95.6%
Knows about important test to
undergo as a HSC donor
Yes 5 (out of  68) 7.4%
No 63 (out of  68) 92.6%
Heard about unrelated HSC donor
registry
Yes 10 (out of  422) 2.4%
No 412 (out of  422) 97.6%
Score obtained by voluntary blood donors in the assessment of knowledge
0 1 2 3 4 5
No.of donors 354 32 21 10 2 3
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Score obtained by voluntary blood donors in the assessment of
knowledge
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Variable Minimum Maximum Mean Std.
Deviation
Score obtained in the
assessment of
knowledge
0 5 0.30 0.808
In this study population (N=422), out of a total score of “6”, minimum
score noted was “0” which was obtained by 354 (83.9%) donors. Maximum
score noted was “5” which was obtained by only 3 (0.7%) donors.
Level of knowledge in voluntary blood donors
In this study population (N=422), 417 (98.8%) of the donors had
“below desirable knowledge” and 5 (1.2%) of the donors had “desirable
knowledge”.
98.8%
1.2%
Level of knowledge regarding HSC
donation and unrelated HSC donor registry in voluntary blood
donors
Below desirable ( n= 417)
Desirable (n=5)
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III. STATISTICS ON ATTITUDE
A. Before providing information
1. Willingness of voluntary blood donors to donate HSCs before
providing information
In this study population (N = 422), 224 (53.1%) of the donors were not
sure about their decision regarding HSC donation, prior to receiving
information. 124 (29.4%) of the donors were willing and 74 (17.5%) of the
donors were not willing to donate HSCs, prior to receiving information.
17.5%
29.4%
53.1%
Willingness of voluntary blood donors to donate HSCs before
providing information
Not willing to donate HSCs
(n= 74)
Willing to donate HSCs
(n=124)
Not sure about decision
regarding HSC donation
(n=224)
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B. After providing information
1. Willingness of voluntary blood donors to donate HSCs
In this study population (N = 422), 170 (40.3%) of the donors were
willing to donate HSCs after receiving information. 135 (32%) of the donors
were not sure about their decision regarding HSC donation and 117 (27.7%)
of the donors were not willing to donate HSCs after receiving information.
27.7%
40.3%
32.0%
Willingness of voluntary blood donors to donate HSCs after
providing information
Not willing to donate HSCs (n=
117)
Willing to donate HSCs
(n=170)
Not sure about decision
regarding HSC donation
(n=135)
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2. Change in attitude after providing information on HSC donation and
unrelated HSC registry
Attitude prior to
providing information
No. of donors who
retained the same
attitude after
information
No. of donors who
changed their
attitude after
information
Willing
to donate HSCs
(n=124)
85
(68.5%)
39
(31.5%)
Not willing
to donate HSCs
(n=74)
52
(70.3%)
22
(29.7%)
Not sure
about decision to donate
(n=224)
101
(45.1%)
123
(54.9%)
12
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and unrelated HSC registry
Not sure
(before information)
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(before information)
Not willing
(before information)
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In this study population (N = 422), 39 (31.5%), 22 (29.7%), and 123
(54.9%) of the donors who were initially willing (n=124), unwilling (n=74)
and not sure about their decision to donate HSCs (n=224), respectively, had
changed their attitude after providing information.
3.  Individuals to whom HSC donation was preferred by willing
voluntary blood donors.
In this study population (N = 422), among the donors who were willing
to donate HSCs (n=170), 151 (88.8%) of them were willing to donate to
anyone in need of HSCs as treatment. 13 (7.6%) of them were willing to
donate only to related individuals and 6 (3.5%) of them were willing to donate
to related and known unrelated individuals.
7.6%
88.8%
3.5%
Individuals to whom donation of HSCs was preferred by willing
voluntary blood donors
Related individuals (n=13)
Anyone ( n= 151)
Related & known unrelated
individuals (n=6)
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4. Willingness to join unrelated HSC donor registry among those
voluntary blood donors who expressed willingness to donate HSCs to
anyone in need
In this study population (N = 422), all the donors who expressed
willingness to donate HSCs to anyone in need (n=151), expressed willingness
to join unrelated HSC donor registry.
5. Willingness for subsequent HSC donation among those voluntary
blood donors who expressed willingness to donate to HSCs to anyone in
need
In this study population (N = 422), among the donors who expressed
willingness to donate HSCs to anyone in need (n=151), 74 (49%) of them
were willing for subsequent donation of HSCs after initial donation. 64
(42.4%) of the donors were not sure about willingness and 13 (8.6%) of the
donors were not willing for subsequent donation of HSCs.
8.6%
49.0%
42.4%
Willingness for subsequent HSC donation among those
voluntary blood donors who expressed willingness to donate
to HSCs to anyone in need
Not willing (n=13)
Willing ( n= 74)
Not sure about willingness
(n=64)
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6. Willingness for subsequent donation of blood or its components among
those donors who expressed willingness to donate HSCs to anyone in
need
In this study population (N = 422), among the donors who expressed
willingness to donate HSCs to anyone in need (n=151), 144 (95.4%) of them
were willing for subsequent donation of blood or its components after initial
donation of HSCs. 7 (4.6%) of the donors were not sure about willingness
regarding subsequent donation of blood or its components after initial
donation of HSCs.
95.4%
4.6%
Willingness for subsequent donation of blood or its
components among those voluntary blood donors who
expressed willingness to donate HSCs to anyone in need
Willing (n= 144)
Not sure about willingness (n= 7)
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7. Reasons given by voluntary blood donors who were not willing or not
sure about willingness to donate HSCs
In this study population (N = 422), reasons given by donors who were
not sure about willingness or not willing to donate HSCs (n=252) were risk /
fear of side effects (36.5%), no interest in HSC donation (16.7%), need to
know more about HSC donation (13.9%), need to discuss with family
members (12.7%), HSC donation requires absence from work(11.5%),
concern about personal situation(2.4%), duration of donation
procedure(1.6%), PBSC donation requiring five days of injection prior to
donation(1.2%) , concern for fitness to donate later, in future (1.2%), need to
grow older to decide (0.8%), dependence of family members on the donor
(0.8%), apheresis-related complications(0.4%), both risk/fear of side-effects
and HSC donation requiring absence from work (0.4%).
36.5%
16.7%
13.9%
12.7%
11.5%
8.7%
Reasons given by voluntary blood donors who were not
willing or not sure about willingness to donate HSCs
Risk/fear of side effects
(n=92)
No interest (n=42)
Need to know more (n=35)
Need to discuss with family
(n=32)
Absence from work(n=29)
Other reasons (n=22)
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8. Response of voluntary blood donors when asked if others’ opinion will
make  them  change their decision to donate HSCs
In this study population (N = 422), 283 (67.1%) of them responded that
others’ opinion would not make them change their decision regarding HSC
donation. 139 (32.9%) of the donors responded that others’ opinion would
make them change their decision regarding HSC donation.
No Yes
Percentage of donors 67.1% 32.9%
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Response of voluntary blood donors when asked if others’
opinion will make them change their decision to donate HSCs
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9. Individuals whose opinion was regarded as important by the voluntary
blood donors  in their decision to donate HSCs
In this study population (N = 422), among the donors who responded
that others’ opinion would make them change their decision regarding HSC
donation (n =139), 111 (79.9%) of the donors considered the opinion of one
or more family members to be important in their decision to donate HSCs.
Opinion of friends, persons who have already donated HSCs and others, like
family doctor, were considered important by 2 (1.4%), 15 (10.8%) and 11
(7.9%) donors, respectively.
Parent
(s)
Sibling
(s) Spouse
Parent
s and
Sibling
s
Parent
s and
Spouse
Parent
s,siblin
gandsp
ouse
Friend
s
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has
donate
d HSCs
Others
No.of donors 86 6 11 1 5 2 2 15 11
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IV. STATISTICS ON BEHAVIOUR
1. Registration status of voluntary blood donors at an unrelated HSC
donor registry
In this study population (N = 422), 3 (0.7%) of the donors had
registered and 419 (99.3%) of the donors were not registered at any unrelated
HSC donor registry.
99.3%
0.7%
Registration status of voluntary blood donors at an unrelated HSC
donor registry
Not registered in unrelated
HSC donor registry(n=419)
Registered in unrelated HSC
donor registry(n=3)
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Donor-related factors and willingness to donate HSCs to unrelated
individuals
VARIABLE
No. of
donors
(N=422)
No. of donors
df Chi-square
p
value
Willingness to donate HSCs
Yes
(n=170)
Yes to
anyone
(n=151)
No/Not
sure
(n=252)
Age
(years)
18-24 262 111 102 151 6 7.007 0.320
25-44 146 53 43 93
45-60 14 6 6 8
Gender
Male 402 163 144 239 3 1.047 0.790
Female 20 7 7 13
Marital status Unmarried 313 132 119 181 3 2.760 0.430
Married 109 38 32 71
Education Illiterate 1 0 0 1 15 8.15 0.918
Primary school 1 0 0 1
Middle school 11 2 2 9
High school 34 12 12 22
High school
diploma
205 68 68 137
Graduation/post-
graduation
170 69 69 101
Past history of
blood donation
No 174 61 56 113 3 6.201 0.102
Yes 248 109 95 139
No. of units of
blood donated
in repeat
donors (n=248)
<5 units 187 76 67 111 3 5.866 0.118
>5 units 61 33 28 28
History of
apheresis
donation
No 415 166 147 249 3 1.567 0.667
Yes 7 4 4 3
Level of
knowledge
Below desirable 417 165 146 252 3 9.081 0.028
Desirable 5 5 5 0
Knows a
person who
needs HSCs as
treatment
No 415 164 145 251 6 10.271 0.114
Yes 7 6 6 1
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1. Age
102(38.9%), 43(29.5%) and 6(42.9%) donors in the 18-24 (n= 262),
25-44 (n= 146) and 45-60 (n=14) age groups, respectively, were willing to
donate HSCs to anyone in need of HSCs as treatment. However, age of the
donor was not significantly associated with willingness to donate HSCs.
2. Gender
144 (35.8%) and 7(35%) of the male (n=402) and female (n=20)
donors, respectively, were willing to donate HSCs to anyone in need of HSCs
as treatment. However, gender was not significantly associated with
willingness to donate HSCs.
3. Marital status
119 (38%) and 32 (29.4%) of the unmarried (n= 313) and married
(n=109) donors, respectively, were willing to donate HSCs to anyone in need
of HSCs as treatment. However, marital status was not significantly
associated with willingness to donate HSCs.
4. Education
69 (40.6%), 68 (33.2%), 12 (35.3%), and 2 (18.1%) of the donors who
had completed graduation/postgraduation, high school diploma, high school
and middle school, were willing to donate HSCs to anyone in need. None of
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the donors who had completed only primary school or had no formal
education were willing to donate HSCs to anyone in need of HSCs as
treatment. However, education was not significantly associated with
willingness to donate HSCs.
5. Blood donation
56 (32.2%) and 95 (38.3%) of the first-time (n=174) and repeat (n=
248) donors, respectively, were willing to donate HSCs to anyone in need of
HSCs as treatment. 67 (35.8%) and 28 (45.9%) of the repeat donors who had
donated less than (n=187) and more than (n=61) 5 units, respectively, were
willing to donate HSCs to anyone in need of HSCs as treatment. However,
number of units of blood donated was not significantly associated with
willingness to donate HSCs.
6. Past history of apheresis
147 (35.4%) and 4(57.1%) of the donors without (n=415) and with
(n=7) history of plateletpheresis donation, respectively, were willing to donate
HSCs to anyone in need of HSCs as treatment. However, past history of
apheresis donation was not significantly associated with willingness to donate
HSCs.
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7. Level of knowledge
146 (35%) and 5 (100%) of the donors with “below desirable” (n=
417) and “desirable” (n= 5) level of knowledge, respectively, were willing to
donate to anyone in need of HSCs as treatment. Level of knowledge was
significantly associated with willingness to donate HSCs.
8. Having a known person who needs HSCs as treatment
6 (85.7%) of the donors who had a known person who needed HSCs
treatment (n=7), were willing to donate HSCs to anyone in need of HSCs as
treatment. 145 (34.9%) of the donors who did not have a known person who
needed HSCs treatment (n= 415), were willing to donate HSCs to anyone in
need of HSCs as treatment. However, having a known person who needed
HSCs as treatment was not significantly associated with willingness to donate
HSCs.
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DISCUSSION
In the present study, among 422 voluntary blood donors, awareness
about HSC donation was found to be 16.1% which is comparable to 18.5%
reported in the study done by Varghese ST et al99 among 81 engineering
college students in Kerala.
In our study, the level of knowledge about HSC donation and unrelated
donor HSC registry was “below desirable” in majority (98.8%) of the donors
and “desirable” only in 5 (1.2%) of the donors. However, the study conducted
among engineering college students in Kerala99 with questions pertaining to
the knowledge assessment about HSC donation revealed 30.9% and 69.1% of
the participants with moderately adequate and inadequate knowledge,
respectively; none of the participants had adequate knowledge about HSC
donation.
In the present study, 2.4% of the voluntary blood donors were aware of
unrelated HSC donor registry. However, in the studies done in South
Carolina100,101 among potential eligible HSC donors, 51.7% and 42.9% of
them were aware of the unrelated HSC donor registry.
In our study, out of the 68 donors who were aware of HSC donation,
34 (50%) donors knew about the purpose of HSC donation, 3 (4.4%) donors
were aware of the risks associated with HSC donation, 5 (7.4%) donors were
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aware of the test to be done as a HSC donor. In similar studies done among
potential eligible HSC donors in South Carolina,100,101 92% and 92.8% of
them, respectively, were aware of HSC transplantation as a life-saving
procedure.
In the present study, among 422 voluntary blood donors, 124 (29.4%)
of the donors were willing to donate HSCs. The percentage of donors willing
to donate HSCs increased from 29.4% to 40.3% after providing information
on HSC donation and unrelated HSC donor registry. Kaya Z et al102 in their
study among college students in Turkey had reported similar increase in the
percentage of participants expressing willingness for HSC donation after
providing information. In another study by Studts JL et al86 in Kentucky, 49%
of the participants agreed to register at an unrelated HSC donor registry after
providing necessary information with regard to HSC donation. Further, in our
study, change in the attitude towards HSC donation was observed after
providing information, notably among the donors who had responded “not
sure” initially.
In our study, out of 170 donors who expressed their willingness after
providing information, 151(88.8%) were willing to donate to anyone and all
151 of them were willing to join unrelated HSC donor registry. However, in
the studies by Kwok J et al88 and Onitilo AA et al101 in Hong Kong and South
Carolina, among potential HSC donors, only 51.5% and 44.7% of those who
were willing to donate HSCs, respectively, expressed willingness to join the
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registry. Such ambivalence was not noted in our study because of our study
population being voluntary blood donors.
In the present study, among the 170 voluntary blood donors who were
willing to donate HSCs, 19 (11.1 %) of them were willing to donate HSCs
only to family and known unrelated individuals. However, in studies done in
Iran and Hong Kong,103,88 among high school students and potential eligible
HSC donors who were willing to donate HSCs, 16% and 25.5% of them,
respectively, expressed willingness to donate only to their family members.
The lower percentage noted in our study compared to these studies could be
due to our study population being voluntary blood donors who are
characterised by their altruistic nature.
In the present study, among 422 voluntary blood donors, 252(59.7%)
of them were either “not sure about decision” or “not willing” to donate
HSCs.
The most frequently noted reasons in the order of priority were
concern about side effects and complications of HSC donation, lack of
interest in HSC donation, need to know more about HSC donation, need to
discuss with family members and time-off from work required for HSC
donation. In studies done by Kwok J et al88 and Ontilo AA et al101 among
potential eligible HSC donors, the reasons for unwillingness to donate HSCs
were of similar nature.
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About 5 to 10% of the HSC donors may be requested for a subsequent
donation of HSCs or blood components after initial HSC donation.95 In this
regard, 49% and 95.4% of the donors in our study expressed willingness for
subsequent HSC and blood component donation, respectively.
In our study, among the 422 voluntary blood donors, 139 (32.9%)
donors responded that others’ opinion would influence their decision
regarding HSC donation. Among these donors, majority (79.9%) considered
that the opinion of one or more family members would influence their attitude
regarding HSC donation. The remaining small proportion of the donors
(20.1%) felt that the opinion of people who have already donated HSCs,
friends and family doctor and were important. McCullough J et al104 in their
study among 150 whole blood or apheresis donors in Minnesota reported that
54% of the donors had discussed with another person, most commonly the
spouse, before enrolling in unrelated HSC donor registry.
In the present study, among the 422 voluntary blood donors, only 3
donors were already registered at an unrelated HSC donor registry. These 3
donors had enrolled during a HSC recruitment drive in their college. The
studies done among general population by Kwok J et al88 and Bart T et al105
revealed that 13.6 % and 22.8%, respectively, were already registered at an
unrelated HSC donor registry.
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Donor-related factors and willingness to donate HSCs to unrelated
individuals
Age
In our study, higher proportion of donors in the 18-24 (38.9%) and 45-
60 (42.9%) years age group than in the 25-44 (29.5%) years age group
expressed willingness to donate HSCs to anyone in need of HSCs as
treatment. However, age was not significantly associated (p = 0.320) with
willingness to donate HSCs, similar to the study results obtained by Volken T
et al106 and Beatty PG et al19. However, in the study by Kwok J et al,88 it was
reported that respondents were more willing to donate to unrelated individuals
if they were in the age groups of 18-46 years. Onitilo AA et al101 also reported
in their study that younger individuals were more willing to donate HSCs.
Gender
In our study, almost equal proportions of male and female donors
(35.8% and 35%, respectively) expressed willingness to donate HSCs to
anyone in need of HSCs as treatment. However, gender was not significantly
associated with willingness to donate HSCs (p = 0.790). This was similar to
results of the studies by Volken T106, Kwok J et al88, Onitilo AA et al101 and
Beatty PG et al.19
However, less male students showed intention to donate HSCs than
female students in the study by Kim M et al107. Studts JL et al86 in their study
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also reported that females were more likely to agree to register at an unrelated
HSC donor registry. However, in the study by Briggs et al108 it was reported
that women were less likely to express willingness to donate HSCs than men.
Marital status
In the present study, higher proportions of unmarried donors (38%)
than married donors (29.4%) were willing to donate HSCs to anyone in need
of HSCs as treatment. However, marital status was not significantly
associated (p = 0.430) with willingness to donate HSCs. Briggs et al108
showed that married people were less likely to express willingness to donate
HSCs than unmarried people. However, Studts JL et al86 had reported in their
study that married participants were more likely to agree to register at an
unrelated HSC donor registry.
Education
In the present study, higher proportion of donors who had completed
graduation/postgraduation, high school diploma and high school than those in
the other levels of education were willing to donate HSCs to anyone in need
of HSCs as treatment. However, education was not significantly associated (p
= 0.918) with willingness to donate HSCs. This was similar to the findings of
Volken T et al106, Sanavi S et al103 and Briggs et al108 in their studies.
However, studies by Onitilo AA et al101, Kwok J et al88 and Laver JH et al100
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showed that individuals with higher levels of education were more willing to
donate HSCs.
Whole blood donation
In the present study, higher proportion of repeat donors (38.3%) than
first time donors (32.2%) were willing to donate HSCs to anyone in need of
HSCs as treatment. Also, higher proportion of repeat donors who had donated
more than 5 units (45.9%) than those who had donated less than 5 units of
blood (35.8%), were willing to donate HSCs to anyone in need of HSCs as
treatment. However, the number of units of blood donated was not
significantly associated (p = 0.118) with willingness to donate HSCs.
However, in the study by Beatty PG et al,19 donors who had given 5 or fewer
units previously had a 5 % probability of joining, donors who had given
between 16 and 20 units had a 38 % probability, and donors with a history of
more than 20 units had a 60 % probability. In contrast, results of the study by
Briggs et al108 showed that the number of prior whole blood donations was
negatively related to willingness to become a HSC donor.
Apheresis donation
In the present study, higher proportion of donors with history of
plateletpheresis (57.1%) donation than those without history of apheresis
donation (35.4%), were willing to donate HSCs to anyone in need of HSCs as
treatment. However, past history of apheresis donation was not significantly
91
associated (p = 0.667) with willingness to donate HSCs. However, in the
study by Briggs et al,108 prior apheresis donation was negatively related to
willingness to become a HSC donor.
Level of knowledge
In the present study, higher proportion of donors with “desirable” level
of knowledge (100%) than those with “below desirable” level of knowledge
(35%), were willing to donate to anyone in need of HSCs as treatment. Level
of knowledge was significantly associated (p = 0.028) with willingness to
donate HSCs which is similar to the results of the study by Kwok J et al88 in
which higher knowledge scores were related to willingness to donate HSCs to
unrelated individuals.
Having a known person who needs HSCs as treatment
In the present study, higher proportion of donors who had a known
person needing HSCs as treatment (85.7%) than those who did not (34.9%),
were willing to donate to anyone in need of HSCs as treatment. However,
having a known person who needs or has needed HSCs as treatment was not
significantly associated (p = 0.114) with willingness to donate HSCs. In the
study by Galanis PA et al109 persons with a relative or a friend in need of
HSCT were more likely to express willingness to donate HSCs. Also, results
of the study by Studts JL et al86 showed that participants who had a family
history of cancer were more likely to agree to register.
SUMMARY
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SUMMARY
The present study on knowledge, attitude and behaviour (KAB) among
422 voluntary blood donors, using pre-and post-interventional study
questionnaire, revealed
• Awareness about HSC donation in 16.1 % (68 out of 422) of the
donors.
• Awareness about unrelated HSC donor registry in 2.4 % (10 out of
422) of the donors
• “Desirable” knowledge in 1.2 % (5 out of 422) of the donors and
“below desirable” knowledge in 98.8% (417 out of 422) of the donors.
• Prior to providing information about HSC donation and unrelated HSC
donor registry, 53.1% (224 out of 422) of the donors were not sure
about willingness, 29.4 % (124 out of 422) of the donors were willing
and 17.5% (74 out of 422) of the donors were unwilling to donate
HSCs.
• After providing information on HSC donation and unrelated HSC
donor registry, 40.3% (170 out of 422) of the donors were willing to
donate HSCs.
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• After providing information, the change in attitude towards HSC
donation was most notable (54.9%) among the category of donors who
responded “not sure” initially.
• Among the 170 donors who were willing to donate HSCs, 88.8% (151
out of 170) of the donors were willing to donate to anyone in need of
HSCs as treatment.
• All the 151 donors who were willing to donate to anyone, were willing
to join unrelated HSC donor registry.
• Among the 151 donors who were willing to donate HSCs to anyone,
49% (74 out of 151) and 95.4% (144 out of 151) of them were willing
for subsequent donation of HSCs and blood components, respectively,
after initial HSC donation.
• Major reasons among donors who did not have a positive attitude
about HSC donation were concern about side effects and complications
of HSC donation, lack of interest in HSC donation, need to know more
about HSC donation, need to discuss with family members and time-
off from work required for HSC donation.
• 32.9% (139 out of 422) of the donors considered that others’ opinion
would make them change their decision regarding HSC
donation.79.9% (111 out of 139) of these donors considered the
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opinion of one or more family members and 20.1% of the donors
considered the opinion of people who have already donated HSCs,
friends and others like family doctor, as important in their decision
regarding HSC donation.
• 3 out of 422 donors had already registered at an unrelated HSC donor
registry.
• Level of knowledge of the donor regarding HSC donation and
unrelated HSC donor registry was significantly associated with
willingness to donate HSCs to unrelated individuals. Other factors like
age, gender, marital status,  education, number of blood units donated,
prior plateletpheresis donation and having a known person who needed
HSCs as treatment, were not significantly associated with willingness
to donate HSCs to unrelated individuals.
CONCLUSION
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CONCLUSION
The present study revealed the existing knowledge, attitude and
behaviour (KAB) among voluntary blood donors regarding HSC donation and
unrelated HSC donor registry.
Knowledge plays a vital role in shaping the attitude towards HSC
donation. Moreover, voluntary blood donors with positive attitude towards
HSC donation need adequate opportunities to act upon their intentions.
Strategies like involving people who have experienced HSC donation
and those who are important in the decision-making process of potential HSC
donors, may be useful for motivation regarding unrelated HSC donation.
Given the wide range of disease conditions potentially curable by
allogeneic HSCT and the dependence of considerable number of patients on
unrelated HSC donors, it is imperative to intensify awareness and recruitment
campaigns among voluntary blood donors.
In a developing country like India with lack of awareness about
unrelated HSC donation and relatively less number of volunteers registered as
potential HSC donors compared to developed nations, it is high time for
policy-makers to take dedicated initiatives to address these issues for
improving health care in our country.
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DONOR INFORMATION SHEET
       KAB STUDY AMONG VOLUNTARY BLOOD DONORS REGARDING THEIR
AWARENESS AND WILLINGNESS TO JOIN STEM CELL REGISTRY AND TO
DONATE HEMATOPOIETIC STEM CELLS
Many diseases like blood & bone marrow cancers, thalassemia are treated by transplanting stem cells
which are capable of forming normal blood cells. These cells can be donated to patients by others if
found suitable.  If donors are not available within family members, donors have to be searched from
unrelated sources.
AIM:
To study the knowledge, attitude and behaviour of voluntary blood donors regarding their
awareness and willingness to join stem cell registry and to donate hematopoietic stem cells.
PROCEDURE:
Being a voluntary blood donor, you are recruited for this study. A questionnaire will be filled by
me as per your response to questions regarding the hematopoietic stem cell donation and stem cell
registry, before and after giving you a handout containing information about the same.
BENEFITS AND RISKS
There is no risk to donors enrolled in this study as this is a KAB study and their blood donation
process is not interfered with.
CONFIDENTIALITY
Your privacy will be protected in so far as permitted by law. Only your researcher and Ethical
committee members will have access to the data collected during the study.
PARTICIPATION
Your participation in this study is voluntary and you are free to decide now or later whether to
continue or discontinue from the study.
NAME OF THE DONOR:
SIGNATURE                   :
DATE                               :
CONSENT
I confirm that I have read and understood the information about the above research
study dated ________________   and I received chance to ask the questions.
My participation in this study is voluntary and I know that I am free to withdraw from
the study at any time, without giving any reason and without affecting of my legal
rights.
I agree to this access. I know that my identification will not be revealed in any details
that is released to third persons or published.
I agree not to restrict or interfere any data or results that are obtained from this study.
I agree to participate in this research study for the above listed purpose.
Donor’s name                 :
Signature                         :                                                              Date:
Signature of the person
who obtains consent      :
Donor ID number          :                                                                Date:


Questionnaire
Questionnaire No. : Date :
Donor Registration No. : Camp site/walkin :
Age (Completed) : Education(completed) :
Gender : male / female
Marital status : unmarried/married
PART ONE:
1. Have you donated blood before?
a) Yes (__ times)      b) No
2. Have you donated blood components by apheresis?
a) Yes       b) No
3. Have you heard about marrow stem cell donation?
a) Yes    b) No (Go to Q.no.9)
4. i) Do you know for what purpose marrow stem cells are donated?
a) Yes     b) No (Go to Q.No.5)
ii) Is there any person known to you who needs/has needed marrow stem cells as treatment?
a) Yes (related / unrelated person)             b) No
5. Do you know about the risks involved in marrow stem cell donation procedure?
a) Yes   b) No
6. Do you know what important test is done before marrow stem cells are donated?
a) Yes   b) No
7. Have you heard about registry for unrelated adult marrow stem cell donors?
a) Yes     b) No (Go to Q.No.9)
8. Have you registered at such a registry?
a) Yes   b) No
9. Are you willing to donate marrow stem cells?
a) Yes    b) No    c) Not sure
PART TWO:
10 Are you willing to donate marrow stem cells?
a) Yes b) No (Go to Q.No.12) c) Not sure (Go to Q.No.12)
11. i) If yes, to whom?
a) FAMILY MEMBERS b) KNOWN UNRELATED PERSONS c) ANYONE IN NEED
ii) If given an opportunity, are you willing to join stem cell registry and donate marrow stem cells
to an unrelated person?
a) Yes    b) No
iii) If yes, are you willing to donate more than once if necessary?
a) Yes b) No c) Not sure
iv) Are you willing to donate blood or its components, if needed, for the same patient?
a) Yes b) No c) Not Sure (Go to Q.No.13)
12. If no or not sure about willingness to donate, give reasons:
13. i) Do you think other’s opinion may make you change your decision?
a) Yes b) No
     ii) If yes, whose opinion?
a) PARENTS b) SIBLING c) SPOUSE d) FRIENDS
e) ANY OTHER PERSON f) PERSON WHO HAS ALREADY DONATED
HANDOUT
? What are marrow stem cells?
- Cells which form red blood cells, white blood cells & platelets.
- They are present in bone marrow, blood (after giving some drugs),
umbilical cord blood.
? Marrow stem cell transplantation
- It is a potentially life-saving treatment for children & adults with
various blood & bone marrow cancers, haemoglobin-disorders,
metabolic & immunity-related diseases.
- Sometimes, it is the only treatment available without which they
may die.
? What is HLA?
- Substance present on the surface of cells called Human leucocyte
Antigen.
- HLA should match closely between donor & patient cells for
success of  transplantation but this is not as simple as blood group
matching.
? Marrow stem cell donation
- Is voluntary
- Donors should be healthy & free from risk of transmittable
diseases.
- Donors are tested for HLA, blood group, infections.
- Donors will not be paid for donation
? Two ways of collection from adult donor:
1. From blood:
- Drug “G-CSF” is injected just below skin, once daily for 5 days;
then stem cells are collected from peripheral vein by apheresis.
-  Common side-effects are bone pain, headache, muscle pain,
tiredness from which donors will recover within few days or by taking
medicines.
 2. Directly from bone marrow
- Under general or spinal anaesthesia, stem cells are collected from
hipbone using  special needle.
- Common side-effects are tiredness, pain at collection site, back pain,
nausea,  headache from which donors will recover by taking
medicines & rest for few days.
? Stem Cell Registry
- Adults, who are voluntarily willing to donate marrow stem cells to
any unrelated patient, anywhere in the world, can join registry.
- Minimum age for joining is 18 years; maximum age is as per
registry policy.
- Registry will store details of donor HLA test in their software.
- Only if donor’s HLA matches with a patient’s HLA, registry will
contact donor.
- Identity of both the patient & donor will not be revealed to each
other.
- Donor may be asked to donate stem cells again or to donate blood
for the same patient if needed.
- Donor has the right to withdraw ANYTIME from the registry.
? Need for more unrelated adult HSC donors in India
- 70% of patients do not have donors within their family.
- They have to rely on unrelated adult donors or public umbilical cord
blood for marrow stem cells.
- There are only 3 public umbilical cord blood banks in India.
- Only about one lakh adults have registered as potential unrelated
donors into the available registries in the country.
- If  patients don’t find donors within them, they will have to search in
foreign registries which is very costly& time-consuming with
practical difficulties.
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VARIABLES/ QUESTION (CODE) RESPONSE CODE
Age of the donor in years (AGE) Digit represents age in years
Gender of the donor (GENDER) 0- Male , 1- Female
Marital Status (MARSTAT) 0 – Unmarried , 1- Married
Education level of the donor (EDU) 7-Profession/Honours,
6-Graduate/postgraduate
5-High school diploma
4-High School
3-Middle school
2-Primary school
1-Illiterate
Have you donated blood before?
(PASTDON)
0-No ,1-Yes
No. of units of blood donated
(NUMDON)
Digit  -  represents  number  of  units
donated
999- Not applicable
Have you donated blood components by
apheresis? (APHER)
0-No , 1-Yes
Have you heard about marrow stem cell
donation? (HRDMSD)
0-No , 1-Yes
Do you know for what purpose marrow stem
cells are donated?(PURPOSE)
0-No,1-Yes, 999- Not applicable
Is  there  any  person  known  to  you  who
needs/has needed marrow stem cells as
treatment?     (NEEDMSD)
0-No, 1-Yes, 999- Not applicable
Do you know about the risks involved in
marrow stem cell donation procedure?
(RISK)
0-No, 1-Yes, 999- Not applicable
Do you know what important test is done
before marrow stem cells are donated?
(TESTREQD)
0-No , 1-Yes , 999- Not applicable
Have you heard about registry for unrelated
adult marrow stem cell donors?
(HRDRGSRY)
0-No , 1-Yes , 999- Not applicable
Score obtained by donor in knowledge
assessment (SCORE)
Digit represents score obtained
Level of knowledge (KLEVEL) 0-Belowdesirable, 1-Desirable
Have you registered at such a registry?
(ENROLLD)
0-No, 1-Yes, 999- Not applicable
VARIABLES/ QUESTION CODE RESPONSE CODE
Before information - Are you willing to
donate marrow stem cells? (WILLNG)
0-No, 1-Yes, 2-Not sure
After information- Are you willing to
donate marrow stem cells?
(WLLNGNOW)
0-No, 1-Yes, 2-Not sure
If yes, to whom? (WHONOW) 0-Related persons
1-Knownunrelated persons
2-Anyone in need
3-Related & known unrelated persons
999-Not applicable
If given an opportunity, are you willing to
join stem cell registry and donate marrow
stem cells to an unrelated person?
(JOINNOW)
0-No, 1-Yes, 2-Not sure
999-Not applicable
If yes, are you willing to donate more than
once if necessary? (REPEATNOW)
0-No, 1-Yes, 2-Not sure,
999-Not applicable
Are you willing to donate blood, if
needed, for the same patient?
(BLDALSO)
0-No, 1-Yes, 2-Not sure
999-Not applicable
If no or not sure about willingness to
donate, give reasons:
(REASON)
0-need to discuss with family
1-risk/fear of side effects
2-not interested
3-need to know more
4-absence from work
6-need to grow older to decide
7-concern for fitness to donate later, in
future
8-both 1 & 4
9-concern about personal situation
10-PBSC donation requiring 5 days of
injection prior to donation
11-duration of donation procedure
12-apheresis-related complications
13-dependence of family members on
the donor
999-Not applicable
Do you think other’s opinion may make
you change your decision?
(OPINION)
0-No, 1-Yes
 If yes, whose opinion?
(WHOSEOPN)
0-parent(s), 1-sibling(s), 2- spouse, 3-
friend,  5-person  who  has  already
donated, 6-others, 7-0,1&2, 8-0&1, 9-
0&2
